4D Molecular Therapeutics
FDMT
FDMT
110 hedge funds and large institutions have $534M invested in 4D Molecular Therapeutics in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more call options, than puts
Call options by funds: $294K | Put options by funds: $286K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
28% less capital invested
Capital invested by funds: $745M → $534M (-$212M)
Holders
110
Holding in Top 10
1
Calls
$294K
Puts
$286K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$3.05M | |
| 3 | +$2.66M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$2.55M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.92M |
Top Sellers
| 1 | -$8.41M | |
| 2 | -$6.32M | |
| 3 | -$4.24M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.52M |
| 5 |
Morgan Stanley
New York
|
-$1.3M |